4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000152
Chairperson & CEO sold 9,500 shares at an average $477.42 ($4,535,480)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-29 | Sale : show line 2 in the form 10b5-1 | −400 | $472.05 | $188,818 | 333,543 | I |
| 2026-09-29 | Sale : show line 3 in the form 10b5-1 | −449 | $472.97 | $212,363 | 333,094 | I |
| 2026-09-29 | Sale : show line 4 in the form 10b5-1 | −80 | $473.86 | $37,908 | 333,014 | I |
| 2026-09-29 | Sale : show line 5 in the form 10b5-1 | −552 | $475.12 | $262,263 | 332,462 | I |
| 2026-09-29 | Sale : show line 6 in the form 10b5-1 | −1,395 | $476.10 | $664,160 | 331,067 | I |
| 2026-09-29 | Sale : show line 7 in the form 10b5-1 | −2,135 | $477.09 | $1,018,581 | 328,932 | I |
| 2026-09-29 | Sale : show line 8 in the form 10b5-1 | −2,309 | $478.10 | $1,103,923 | 326,623 | I |
| Open-market sales · 9,500 sh · avg $477.42 · $4,535,480 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-29 | Exercise or conversion : show line 14 in the form 10b5-1 Stock Option | −9,500 | 337,910 | I |
Loading xslF345X06/primarydocument.xml…